Research Professor at CIC BioGUNE

The Center for Cooperative Research in Biosciences CIC BIOGUNE together with Ikerbasque invites applications for a Research Professor position in


We seek for candidates with wide experience in different areas of bioinformatics and computational biology. In particular, expertise in the development and application of Bioinformatics and Systems Biology approaches to key areas in biomedicine, such as Stem Cell Research, Tissue Regeneration and Disease Modelling. 

The applicants should have a proven career of excellence in research as PI in this area as well as a successful record of collaborative projects with top worldwide experimental labs working in these areas (publications, funded grant applications, etc). They should also have demonstrated extended experience as mentors, supervising Postdocs and Ph.D. students. Industry experience would also be an asset. 

The successful candidate is expected to complement and extend the scientific strengths of CIC bioGUNE, to mentor PhD and Postdoc associates, as well as to build internal and external collaborations.  

The cutting-edge scientific activity of CIC bioGUNE researchers explores the interface between Chemistry and Biomedicine, with emphasis on Structural, Molecular and Cell Biology. Two research programmes - "Molecular Recognition and Host-Pathogen Interactions" and "Metabolism and Cell Signaling in Disease" – are made up of more than a hundred forty scientists and technicians, who concentrate on the molecular bases and mechanisms of disease to create new diagnostic methods and promote development of advanced therapies.

CIC bioGUNE has been recently distinguished with the Severo Ochoa mention of Excellence.

Candidates should provide a Cover Letter, Curriculum Vitae, detailed description of research interests and contact information of three references. Only researchers with a strong record of research and group leading experience will be considered. 

All applicants are invited to submit a detailed curriculum vitae to before November 15th 2017, stating reference 42021 in the subject of the email.